Medicine recalls
|
| |
| The United States: Continuum Labs LGD-4033 by Invisiblu International: Recall - investigational drug not approved for use |
| |
Invisiblu International LLC is voluntarily recalling one lot of Continuum Labs LGD-Xtreme, 3 mg to the retail and consumer level. The product has been found to contain LGD-4033 Ligandrol, an investigational drug not approved for use. The risks of using this product are unknown. The affected LGD-Xtreme lot numbers are 21511166 with expiration dates of 11/2018.
LGD-Xtreme is marketed as a dietary supplement to promote gains of lean muscle mass. The product is packaged in a dark amber plastic bottle with ninety capsules. The product can be identified by its black label with gold trim and the Continuum Labs logo. LGD-Xtreme was sold to select end consumers in the United States via the Internet, and was exported to wholesalers in Brazil.
Invisiblu International LLC is asking anyone in possession of this product to stop using and discard any unused capsules.
Please refer to the following website in FDA for details:
http://www.fda.gov/Safety/MedWatch/../ucm494168.htm
In Hong Kong, the above product is not a registered pharmaceutical product, and there is no registered pharmaceutical product containing ligandrol.
Ends/ Wednesday, April 06, 2016
Issued at HKT 15:00
|
| |
